Brighthouse Financial (BHF) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
15 Oct, 2026Executive summary
Q4 net loss available to shareholders was $942M, or $14.70 per diluted share; adjusted earnings were $177M, or $2.73 per share, and adjusted earnings less notable items were $189M, or $2.92 per share.
FY 2023 net loss available to shareholders was $1.214B; adjusted earnings less notable items totaled $930M, versus $1.12B in FY 2022.
Full-year annuity sales reached $10.6B, supported by Shield Level annuities; life sales were $102M.
Financial highlights
Adjusted earnings less notable items were $189M in Q4 2023, versus $275M in Q3 2023 and $282M in Q4 2022.
Q4 adjusted earnings were $177M, versus $545M in Q4 2022; Q4 2023 included a $12M unfavorable legal item.
Q4 net investment income was $1.207B; adjusted net investment income was $1.226B, up $144M QoQ, with a 4.16% yield.
Alternative investment yield was 0.7% for the quarter, and net investment income was ~$60M below quarterly run-rate expectations post-tax; corporate expense seasonality also affected results.
Q4 corporate expenses were $244M pre-tax, versus $243M in Q4 2022 and $210M in Q3 2023.
Outlook and guidance
Long-term annual share repurchase expectation was 9%–11%; ~$763M remained under authorizations after ~$30M of additional YTD repurchases through February 9, 2024.
Statutory capital management uses a maximum loss tolerance and manages Shield and variable-annuity risk on a combined basis.
Latest events from Brighthouse Financial
- Q2 2026 net income hit $956M, with strong annuity sales and a pending $4.1B acquisition.BHF
Q2 2026 - All board-recommended proposals passed, including director elections and Say-on-Pay.BHF
AGM 2026 - Net loss widened to $792M, adjusted earnings rose, and the Aquarian merger remains on track.BHF
Q1 2026 - Virtual meeting to elect nine directors, ratify auditor, and approve executive pay.BHF
Proxy filing - Pending merger, record sales, and strong governance define this year's proxy highlights.BHF
Proxy filing - Q4 net income declined, but record annuity and life sales and a pending $4.1B acquisition marked 2025.BHF
Q4 2025 - Merger and related proposals were approved by stockholders as recommended by the board.BHF
EGM 2026 - Shareholders to vote on merger amid litigation and board's unanimous support.BHF
Proxy Filing - Adjusted earnings reached $346M with record life sales, but statutory capital and RBC ratio declined.BHF
Q2 2024